Your session is about to expire
← Back to Search
Social-Emotional Learning for Domestic Violence (R-CITY Trial)
N/A
Recruiting
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
- General education teachers of core subjects (Mathematics, Science, Social Studies, English/Language Arts)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention, within one month following the completion of the intervention.
Awards & highlights
No Placebo-Only Group
Summary
This trial uses 4 "Rs" to create a safe & positive learning environment for all: Recognizing, Responding, Restoring Relationships & Resilience. It aims to build equity stamina & enhance SEL skills.
Who is the study for?
The R-CITY Project is for general education teachers of core subjects like Math, Science, Social Studies, and English in Anne Arundel County Public Schools. It aims to enhance their ability to create a positive learning environment by integrating equity literacy with social and emotional learning (SEL).
What is being tested?
This study compares two educational approaches: 'SEL + Equity', which combines SEL curriculum with equity lessons, versus 'SEL Only', the standard SEL program. The goal is to see if adding equity training improves school environments.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no traditional side effects. However, participants may experience challenges adapting new teaching methods or changes in classroom dynamics.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-intervention, within one month following the completion of the intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, within one month following the completion of the intervention.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
ASSIST Classroom Observations
Secondary study objectives
R-CITY Teacher Self-Report Survey
Suspensions
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SEL + EquityExperimental Treatment1 Intervention
SEL + Equity (Second Step + Equity) supports include supports from the SEL Only condition plus:
* Training and implementation support for teachers to deliver 6 equity literacy lessons tailored to each grade level (4th and 5th for elementary schools; 6th - 8th for middle schools) and aligned with Second Step core content
* Five 45-minute school-wide equity focused Professional Development (PD) sessions to complement AACPS Equity PD
* Individualized teacher coaching to support implementing equity practices and equity-focused classroom lessons
Group II: SEL OnlyActive Control1 Intervention
SEL Only Condition supports include:
* School wide support for implementation of Second Step curriculum (e.g., technical assistance professional development, facilitated professional learning communities)
* Support to Positive Behavioral Intervention and Supports (PBIS) and Multi Tiered System of Supports (MTSS) and equity teams with alignment of initiatives
* Individualized technical assistance with Second Step SEL implementation
Find a Location
Who is running the clinical trial?
National Institute on Minority Health and Health Disparities (NIMHD)NIH
443 Previous Clinical Trials
1,412,931 Total Patients Enrolled
Sheppard Pratt Health SystemOTHER
22 Previous Clinical Trials
7,524 Total Patients Enrolled
University of VirginiaLead Sponsor
785 Previous Clinical Trials
1,316,126 Total Patients Enrolled
Johns Hopkins Bloomberg School of Public HealthOTHER
431 Previous Clinical Trials
2,139,436 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: SEL Only
- Group 2: SEL + Equity
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.